The global Breakthrough Therapy Designation market size is expected to be worth around US$ 244.6 billion by 2030, according to a new report by Vision Research Reports.
The global Breakthrough Therapy Designation market size was valued at US$ 54.1 billion in 2020 and is anticipated to grow at a CAGR of 24.1% during forecast period 2021 to 2030.
Breakthrough Therapy (BT) designation is granted to drugs that display substantial results in the treatment of life-threatening diseases in the initial stages of the drug development process. Expedited regulatory process in North America and EU regions is driving growth. An increase in the number of innovative molecules receiving the BT status, coupled with a rise in the demand for orphan drugs as well as those for the treatment of cancer, is anticipated to boost the market over the forecast period.
The development time of BT therapy is 30.0% to 50.0% lesser than those without the designation. This significantly increases the net present value of the investigational molecule. Reduction in the development time of these drugs is expected to accelerate their approval process as compared to standard drugs as well as boost growth opportunities. The BT tag also increases the value of the drug due to its high scientific value.
There has been a consistent rise in the number of drugs receiving BT status in the U.S., and this trend is also expected to drive the number of applications submitted for the same, thereby contributing to the market growth.
The infectious diseases segment dominated the market in 2016. This can be attributed to an increase in sales of blockbuster drugs such as Harvoni and Sovaldi. In addition, a significant number of anti-infective drugs are gaining BT status. However, the decline in sales of blockbuster medicines, coupled with an increase in competition in the hepatitis C market, is expected to restrain the infectious disease segment over the forecast period.
The oncology segment is expected to surpass the infectious disease segment over the forecast period because of growth in the number of anticancer drugs gaining BT status. As of 2016, anticancer drugs were the largest of a number of drugs that gained BT status. The rise in the prevalence of cancer across the globe is anticipated to boost the oncology segment.
The rare disease segment is expected to exhibit the fastest growth over the forecast period. This segment does not include rare cancer diseases as they are covered under the oncology segment. Drugs for rare diseases receive the “Orphan Drug” designation if they are able to diagnose, treat, or prevent diseases that occur in less than 2,00,000 patients in the U.S. 50.0% tax credit is granted for the clinical research for these drugs.
According to the report titled “Insights into Rare Disease Drug Approval: Trends and Recent Developments” by U.S. FDA, rare disease noncancer approval accounts for 23.0% of total BT approval since 2013. Canakinumab (Ilaris) and Asfotase Alfa are among the highest selling medicines for rare diseases as of 2016. The number of molecules approved for rare diseases is expected to increase, and this is expected to boost the market over the forecast period.
North America held the largest share of the global BT designation market owing to favorable IP laws and regulatory environment that rewards innovation through patent and data protection. High per capita income, improved access to healthcare, an increase in the prevalence of chronic diseases, and a rise in preference for innovative drugs by consumers are among major factors driving the market.
The European market is the second-largest market for BT drugs owing to better infrastructure and reimbursement policies. Consumers in this region prefer innovative medicines. According to the European Federation of Pharmaceutical Industries and Associations, diseases related to the cardiovascular system, cancer, respiratory system, digestive system, and nervous system are among major causes of death in Europe.
Asia Pacific and Latin America are expected to exhibit lucrative growth over the forecast period owing to the development of favorable IP laws and a rise in per capita healthcare expenditure in these regions. Preference for generic products in countries such as India and China is estimated to be one of the major challenges for the growth of innovative medicines.
F. Hoffmann-La Roche Ltd; Gilead; Novartis AG; Pfizer, Inc.; AbbVie, Inc.; Janssen Global Services, LLC; Bristol-Myers Squibb Company; Eli Lilly and Company; Sanofi; Regeneron; Acadia Pharmaceuticals, Inc.; Boehringer Ingelheim GmbH; Amgen, Inc.; AstraZeneca; and GlaxoSmithKline plc.
The Middle East and Africa (MEA)
The Breakthrough Therapy Designation market research report covers definition, classification, product classification, product application, development trend, product technology, competitive landscape, industrial chain structure, industry overview, national policy and planning analysis of the industry, the latest dynamic analysis, etc., and also includes major. The study includes drivers and restraints of the global market. It covers the impact of these drivers and restraints on the demand during the forecast period. The report also highlights opportunities in the market at the global level.
The report provides size (in terms of volume and value) of Breakthrough Therapy Designation market for the base year 2020 and the forecast between 2021 and 2030. Market numbers have been estimated based on form and application. Market size and forecast for each application segment have been provided for the global and regional market.
This report focuses on the global Breakthrough Therapy Designation market status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Breakthrough Therapy Designation market development in United States, Europe and China.
It is pertinent to consider that in a volatile global economy, we haven’t just conducted Breakthrough Therapy Designation market forecasts in terms of CAGR, but also studied the market based on key parameters, including Year-on-Year (Y-o-Y) growth, to comprehend the certainty of the market and to find and present the lucrative opportunities in market.
In terms of production side, this report researches the Breakthrough Therapy Designation capacity, production, value, ex-factory price, growth rate, market share for major manufacturers, regions (or countries) and type.
In terms of consumption side, this report focuses on the consumption of Breakthrough Therapy Designation by regions (countries) and application.
Buyers of the report will have access to verified market figures, including global market size in terms of revenue and volume. As part of production analysis, the authors of the report have provided reliable estimations and calculations for global revenue and volume by Type segment of the global Breakthrough Therapy Designation market. These figures have been provided in terms of both revenue and volume for the period 2017 to 2030. Additionally, the report provides accurate figures for production by region in terms of revenue as well as volume for the same period. The report also includes production capacity statistics for the same period.
With regard to production bases and technologies, the research in this report covers the production time, base distribution, technical parameters, research and development trends, technology sources, and sources of raw materials of major Breakthrough Therapy Designation market companies.
Regarding the analysis of the industry chain, the research of this report covers the raw materials and equipment of Breakthrough Therapy Designation market upstream, downstream customers, marketing channels, industry development trends and investment strategy recommendations. The more specific analysis also includes the main application areas of market and consumption, major regions and Consumption, major Chinese producers, distributors, raw material suppliers, equipment providers and their contact information, industry chain relationship analysis.
The research in this report also includes product parameters, production process, cost structure, and data information classified by region, technology and application. Finally, the paper model new project SWOT analysis and investment feasibility study of the case model.
Overall, this is an in-depth research report specifically for the Breakthrough Therapy Designation industry. The research center uses an objective and fair way to conduct an in-depth analysis of the development trend of the industry, providing support and evidence for customer competition analysis, development planning, and investment decision-making. In the course of operation, the project has received support and assistance from technicians and marketing personnel in various links of the industry chain.
The Breakthrough Therapy Designation market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to Breakthrough Therapy Designation market.
Prominent players in the market are predicted to face tough competition from the new entrants. However, some of the key players are targeting to acquire the startup companies in order to maintain their dominance in the global market. For a detailed analysis of key companies, their strengths, weaknesses, threats, and opportunities are measured in the report by using industry-standard tools such as the SWOT analysis. Regional coverage of key companies is covered in the report to measure their dominance. Key manufacturers of Breakthrough Therapy Designation market are focusing on introducing new products to meet the needs of the patrons. The feasibility of new products is also measured by using industry-standard tools.
Key companies are increasing their investments in research and development activities for the discovery of new products. There has also been a rise in the government funding for the introduction of new Breakthrough Therapy Designation market. These factors have benefited the growth of the global market for Breakthrough Therapy Designation. Going forward, key companies are predicted to benefit from the new product launches and the adoption of technological advancements. Technical advancements have benefited many industries and the global industry is not an exception.
New product launches and the expansion of already existing business are predicted to benefit the key players in maintaining their dominance in the global market for Breakthrough Therapy Designation. The global market is segmented on the basis of region, application, en-users and product type. Based on region, the market is divided into North America, Europe, Asia-Pacific, Latin America and Middle East and Africa (MEA).
In this study, the years considered to estimate the market size of Breakthrough Therapy Designation are as follows:
Reasons to Purchase this Report:
- Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
- Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
- Market value USD Million and volume Units Million data for each segment and sub-segment
- Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
- Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
In-depth interviews and discussions were conducted with several key market participants and opinion leaders to compile the research report.
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.
Market Size Estimation
Top-down and bottom-up approaches are used to estimate and validate the global market size for company, regional division, product type and application (end users).
The market estimations in this report are based on the selling price (excluding any discounts provided by the manufacturer, distributor, wholesaler or traders). Market share analysis, assigned to each of the segments and regions are achieved through product utilization rate and average selling price.
Major manufacturers & their revenues, percentage splits, market shares, growth rates and breakdowns of the product markets are determined through secondary sources and verified through the primary sources.
All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or others factors are accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Vision Research Reports and presented in this report.
Market Breakdown and Data Triangulation
After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation. Extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report.
Secondary Sources occupies approximately 25% of data sources, such as press releases, annual reports, Non-Profit organizations, industry associations, governmental agencies and customs data, and so on. This research study includes secondary sources; directories; databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), TRADING ECONOMICS, and avention; Investing News Network; statista; Federal Reserve Economic Data; annual reports; investor presentations; and SEC filings of companies.
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product manufacturers (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.
The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end users (product buyers), and related key executives from various key companies and organizations operating in the global market.
The study objectives of this report are:
Neuro-navigation Systems Market (By Product Type: Optical System, Electromagnetic System; By Application; By End-user) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2022-2030Read more...
Forensic Genomics Market (By Solution: Kits, Analyzers & Sequencers, Software, Consumables; By Method; By Application) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2022-2030Read more...
Personalized Medicine Biomarkers Market (By Technology: Liquid Biopsy; By Application: Oncology, Cardiology) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2022-2030Read more...
3D Printed Prosthetics Market (By Product Type: Sockets, Limbs, Joints, Covers; By Material; By End-Use)- Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2022-2030Read more...
Vulvovaginal Candidiasis Treatment Market (By Drug Type: Clotrimazole, Nystatin, Fluconazole; By Route Of Administration; By Distribution Channel) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2022-2030Read more...